Tri Ppvog HS 2mg/500mg/0.3mg Tablet
Marketer
Elinor Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Tri Ppvog HS 2mg/500mg/0.3mg Tablet
Alogliptin-pioglitazone-metformin combination tablets (2mg/500mg/0.3mg) are classified as antidiabetic agents. This triple-combination medication manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to hyperglycemia and increased risk of complications like nephropathy, retinopathy, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are vital for diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Learn to recognize its symptoms (sweating, dizziness, headache, tremors) and appropriate countermeasures. Maintain regular mealtimes and carry a fast-acting glucose source (e.g., sugary snacks, juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your physician before commencing treatment. Pregnant or lactating individuals should seek medical advice prior to use. Regular blood glucose monitoring and periodic blood tests (complete blood count, liver function tests) are recommended as directed by your doctor.
Primary Ingredients of Tri Ppvog HS 2mg/500mg/0.3mg Tablet
No text provided to rephrase.
Uses of Tri Ppvog HS 2mg/500mg/0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Tri Ppvog HS 2mg/500mg/0.3mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Tri Ppvog HS 2mg/500mg/0.3mg Tablet on an empty stomach.
Common Side effects of Tri Ppvog HS 2mg/500mg/0.3mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Tri Ppvog HS 2mg/500mg/0.3mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Tri Ppvog HS 2mg/500mg/0.3mg Tablet should be consumed on an empty stomach.
How Tri Ppvog HS 2mg/500mg/0.3mg Tablet works:
Each Tri Ppvog HS 2mg/500mg/0.3mg tablet contains a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Tri Ppvog HS 2mg/500mg/0.3mg Tablet is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Tri Ppvog HS 2mg/500mg/0.3mg Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Tri Ppvog HS 2mg/500mg/0.3mg Tablet while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Tri Ppvog HS 2mg/500mg/0.3mg tablets is likely unsafe for individuals with kidney impairment and should be avoided. Medical advice from a physician is recommended. Furthermore, this medication is unsuitable for patients exhibiting severe kidney disease.
LiverCAUTION
Patients with liver disease should use Tri Ppvog HS 2mg/500mg/0.3mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver impairment, initiation with a reduced dose is typical; however, its use is contraindicated in patients with severe liver disease.
What if you forget to take Tri Ppvog HS 2mg/500mg/0.3mg Tablet :
Should you forget a Tri Ppvog HS 2mg/500mg/0.3mg Tablet, take it immediately if you remember. However, near the time for your next scheduled dose, omit the missed one and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Tri Ppvog HS 2mg/500mg/0.3mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
3,018 People bought this recently